Cancer Center Administration

癌症中心管理

• 批准号: 10229631
• 负责人: WENDY LAW
• 金额: $ 18.16万
• 依托单位: FRED HUTCHINSON CANCER RESEARCH CENTER
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-01-01 至 2024-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10229631
• 关键词: Administrator; Area; Attention; Cancer Center; Cancer Center Support Grant; Catchment Area; Clinical Trials; Collaborations; Communities; Community Outreach; Data; Development; Ensure; Evaluation; Faculty; Feedback; Funding; Goals; Grant; Guidelines; Heart; Infrastructure; Institution; Interdisciplinary Study; Intervention Trial; Journals; Leadership; Maintenance; Malignant Neoplasms; Measures; Mind; Monitor; Philanthropic Fund; Process; Publications; Recommendation; Research; Research Support; Resource Allocation; Resource Sharing; Resources; Science; Secure; Strategic Planning; Training and Education; Universities; Vision; Washington; Work; anticancer research; career; design; improved; innovation; meetings; member; mouse model; operation; pre-clinical; programs; ranpirnase; success; symposium; tumor

PROJECT SUMMARY: ADMINISTRATION The Consortium Administration provides high quality, efficient, and effective support to Fred Hutch/University of Washington Cancer Consortium leaders, Research Programs, Shared Resources, and members. Administration owns and drives the processes that Consortium scientific leaders use to define the Consortium's vision and strategic goals, implement initiatives, monitor progress in achieving objectives, and secure needed resources to develop and maintain the requisite infrastructure. Consortium Director Dr. Gary Gilliland and senior leaders developed a strategic plan through a process started when he arrived in 2015. The process is ongoing by design with annual internal and external evaluations of milestones. Throughout the process Administration ensures that CCSG guidelines are integral to the strategic goals and activities. As a result of these activities, Consortium membership has grown by >170 members; cancer-relevant grant funding for the Consortium is at $242M, of which $50M is from the NCI; interventional trials have 5,424 accruals and non-interventional trials have 5,292 accruals (increases of 83% and 20%, respectively, from FY 2014 to FY 2018); and members have over 6,600 cancer-related publications as authors and co-authors, with 11% of them in journals with impact factors greater than 20. New in this cycle of the CCSG are the components for Community Outreach & Engagement (COE) and Cancer Research Career Enhancement (CRCE). Administration has been pivotal to establishing offices for both of these new components to oversee their respective areas of activity. Other new Consortium initiatives include the formation of three Integrated Research Centers (IRCs), the continued development of the Seattle Translational Tumor Research initiative (STTR), and major enhancements of clinical trials infrastructure. Administration has interfaced with initiative leaders and their respective administrators in order to leverage strengths and resources toward supporting Research Programs and members. Finally, as a result of faculty feedback, a new developing Shared Resource for preclinical mouse models was developed by Administration to further Consortium science. `

项目摘要：管理 财团管理为Fred Hutch/University提供高质量，高效和有效的支持 华盛顿癌症联盟的领导者，研究计划，共享资源和成员。 政府拥有并驱动了联盟科学领导人用来定义的过程 财团的愿景和战略目标，执行倡议，监控实现目标的进展以及 安全所需的资源来开发和维护必要的基础架构。财团主任加里博士 吉利兰德（Gilliland）和高级领导人通过一项过程制定了战略计划，该程序始于2015年。 通过设计和外部评估里程碑的设计正在进行中。整个 流程管理确保CCSG指南是战略目标和活动不可或缺的一部分。作为 这些活动的结果，财团会员资格已增长> 170名成员。与癌症相关的补助金 财团为2.42亿美元，其中5000万美元来自NCI；介入的试验有5,424个应计和 非际交往试验具有5,292个应计（分别增加了83％和20％，从2014财年到FY 2018）;成员作为作者和合着者有6,600多个与癌症有关的出版物，其中11％ 在影响因素大于20的期刊中。 在CCSG的这个周期中，新的是社区推广与参与的组成部分（COE）和 癌症研究职业增强（CRCE）。管理一直是建立办事处的关键 这两个新组件都可以监督其各自的活动领域。其他新联盟倡议 包括形成三个综合研究中心（IRC），这是西雅图的持续发展 转化肿瘤研究计划（STTR）以及临床试验基础设施的主要增强。 行政管理已与倡议领导人及其各自的管理人员联系起来，以利用 支持研究计划和成员的优势和资源。最后，由于教师 反馈是管理临床前鼠标模型的新开发的共享资源 进一步的财团科学。 `